- Home
- ZDGE vs STTK Comparison
ZDGE vs STTK Comparison
Compare ZDGE & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- STTK
- Stock Information
- Founded
- ZDGE 2008
- STTK 2016
- Country
- ZDGE United States
- STTK United States
- Employees
- ZDGE N/A
- STTK N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- STTK Health Care
- Exchange
- ZDGE Nasdaq
- STTK Nasdaq
- Market Cap
- ZDGE 40.3M
- STTK 37.6M
- IPO Year
- ZDGE N/A
- STTK 2020
- Fundamental
- Price
- ZDGE $3.81
- STTK $0.83
- Analyst Decision
- ZDGE
- STTK Hold
- Analyst Count
- ZDGE 0
- STTK 4
- Target Price
- ZDGE N/A
- STTK $3.00
- AVG Volume (30 Days)
- ZDGE 419.5K
- STTK 423.3K
- Earning Date
- ZDGE 06-12-2025
- STTK 07-31-2025
- Dividend Yield
- ZDGE N/A
- STTK N/A
- EPS Growth
- ZDGE N/A
- STTK N/A
- EPS
- ZDGE N/A
- STTK N/A
- Revenue
- ZDGE $29,511,000.00
- STTK $4,606,000.00
- Revenue This Year
- ZDGE N/A
- STTK N/A
- Revenue Next Year
- ZDGE $1.07
- STTK N/A
- P/E Ratio
- ZDGE N/A
- STTK N/A
- Revenue Growth
- ZDGE 1.27
- STTK 69.65
- 52 Week Low
- ZDGE $1.73
- STTK $0.69
- 52 Week High
- ZDGE $4.38
- STTK $4.99
- Technical
- Relative Strength Index (RSI)
- ZDGE 58.35
- STTK 38.86
- Support Level
- ZDGE $3.88
- STTK $0.75
- Resistance Level
- ZDGE $4.30
- STTK $0.85
- Average True Range (ATR)
- ZDGE 0.24
- STTK 0.09
- MACD
- ZDGE -0.06
- STTK -0.01
- Stochastic Oscillator
- ZDGE 18.05
- STTK 9.59
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.